Thursday, May 23, 2019 10:15:12 PM
Here are some predictions:
1. There will be no PR of any sort prior to or after ASCO for the short to intermediate term;
2. There will, almost assuredly, be a "sort" of update on the SAPs. LP will state that they are nearing completion and will be submitted "soon" to the relevant RAs. She will not venture a guess on when these submissions will be approved because this is out of her control. Stay tuned.
3. Wrt to collection of data and resolution of inquiries, she will only state that this is a ginormous task but we are getting there. Stay tuned.
4. There will be no guideline on when top line will be announced. " We are pedal to the metal however as stated previously, there are areas out of our control. We understand investor frustrations but patience is important. As soon as we can, top line will be revealed. Stay tuned."
5. Number of patients currently alive will not be revealed. All part of top line announcement.
6. Vague information on the combo trials and partners. "We are focusing on getting to DC VAX L top line."'
7. No other information of any significance. Pretty much the same as the Rago update, with no new information. That is why the stock got slapped today. Nothing really new. Essentially, MB will provide a regurgitation and that they are excitedly awaiting unblinding. Pretty much in Rago's footsteps. Stay tuned.
Monday, June 3, the stock gets punished and will hit the mid to lower twenty cent range. As the summer wears on, with no news, the stock will hit new lows, probably mid-teens. Even with impressive top line, it won't be unequivocal or irrefutable at least in some respects. I don't expect the stock price to achieve even one dollar upon top line announcement. Much less if at all, if top line is not unequivocally impressive.
Unfortunately, if ASCO comes and goes with nothing of real significance, it is another wasted opportunity and further testament to LP/LG strategy of silence, equivocation and obfuscation. ASCO is an opportunity to change the pattern. Surely, there must be something of note that can be revealed at ASCO to mitigate assault on the stock price. If it hits new lows, much of top line news, if good, will be spent on recovering current levels. Surely, NWBO management understands this. Fingers crossed and stay tuned.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM